Search Results - Kai Dallmeier
- Showing 1 - 17 results of 17
-
1
-
2
Luminescence-based Antiviral Assay for Hepatitis E Virus by Yannick Debing, Kai Dallmeier, Johan Neyts
Published in Bio-Protocol (2014-08-01)Get full text
Article -
3
Infectious Virus Yield Assay for Hepatitis E Virus by Yannick Debing, Kai Dallmeier, Johan Neyts
Published in Bio-Protocol (2014-08-01)Get full text
Article -
4
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice by Dieudonné Buh Kum, Robbert Boudewijns, Ji Ma, Niraj Mishra, Dominique Schols, Johan Neyts, Kai Dallmeier
Published in Emerging Microbes and Infections (2020-01-01)Get full text
Article -
5
-
6
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice by Ji Ma, Robbert Boudewijns, Lorena Sanchez-Felipe, Niraj Mishra, Thomas Vercruysse, Dieudonné Buh Kum, Hendrik Jan Thibaut, Johan Neyts, Kai Dallmeier
Published in Emerging Microbes and Infections (2021-01-01)Get full text
Article -
7
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge by Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, Winston Chiu, Thomas Vercruysse, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Lorena Sanchez-Felipe, Kai Dallmeier
Published in npj Vaccines (2023-07-01)Get full text
Article -
8
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine by Sven Göbel, Ozeir Kazemi, Ji Ma, Ingo Jordan, Volker Sandig, Jasmine Paulissen, Winnie Kerstens, Hendrik Jan Thibaut, Udo Reichl, Kai Dallmeier, Yvonne Genzel
Published in Vaccines (2024-07-01)Get full text
Article -
9
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses by Nadia Oreshkova, Sebenzile K. Myeni, Niraj Mishra, Irina C. Albulescu, Tim J. Dalebout, Eric J. Snijder, Peter J. Bredenbeek, Kai Dallmeier, Marjolein Kikkert
Published in Vaccines (2021-12-01)Get full text
Article -
10
Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19 by Joran Degryse, Elke Maas, Ria Lassaunière, Katrien Geerts, Yana Kumpanenko, Birgit Weynand, Piet Maes, Johan Neyts, Hendrik Jan Thibaut, Yeranddy A. Alpizar, Kai Dallmeier
Published in Microorganisms (2024-12-01)Get full text
Article -
11
Ex vivo gut cultures of Aedes aegypti are efficiently infected by mosquito-borne alpha- and flaviviruses by Ana Lucia Rosales Rosas, Lanjiao Wang, Sara Goossens, Arno Cuvry, Li-Hsin Li, Nanci Santos-Ferreira, Alina Soto, Kai Dallmeier, Joana Rocha-Pereira, Leen Delang
Published in Microbiology Spectrum (2023-10-01)Get full text
Article -
12
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields by Sven Göbel, Tilia Zinnecker, Ingo Jordan, Volker Sandig, Andrea Vervoort, Jondavid de Jong, Jean-Simon Diallo, Peter Satzer, Manfred Satzer, Kai Dallmeier, Udo Reichl, Yvonne Genzel
Published in Vaccines (2025-07-01)Get full text
Article -
13
Multiplexed multicolor antiviral assay amenable for high-throughput research by Li-Hsin Li, Winston Chiu, Yun-An Huang, Madina Rasulova, Thomas Vercruysse, Hendrik Jan Thibaut, Sebastiaan ter Horst, Joana Rocha-Pereira, Greet Vanhoof, Doortje Borrenberghs, Olivia Goethals, Suzanne J. F. Kaptein, Pieter Leyssen, Johan Neyts, Kai Dallmeier
Published in Nature Communications (2024-01-01)Get full text
Article -
14
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models by Ji Ma, Michael Bright Yakass, Sander Jansen, Bert Malengier-Devlies, Dominique Van Looveren, Lorena Sanchez-Felipe, Thomas Vercruysse, Birgit Weynand, Mahadesh Prasad Arkalagud Javarappa, Osbourne Quaye, Patrick Matthys, Tania Roskams, Johan Neyts, Hendrik Jan Thibaut, Kai Dallmeier
Published in EBioMedicine (2022-09-01)Get full text
Article -
15
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long... by Bas Calcoen, Nico Callewaert, Aline Vandenbulcke, Winnie Kerstens, Maya Imbrechts, Thomas Vercruysse, Kai Dallmeier, Johan Van Weyenbergh, Piet Maes, Xavier Bossuyt, Dorinja Zapf, Kersten Dieckmann, Kim Callebaut, Hendrik Jan Thibaut, Karen Vanhoorelbeke, Simon F. De Meyer, Wim Maes, Nick Geukens
Published in Viruses (2022-06-01)Get full text
Article -
16
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters by Robbert Boudewijns, Patricia Pérez, Patricia Pérez, Adrián Lázaro-Frías, Adrián Lázaro-Frías, Dominique Van Looveren, Thomas Vercruysse, Hendrik Jan Thibaut, Birgit Weynand, Lotte Coelmont, Johan Neyts, David Astorgano, Dolores Montenegro, Eugenia Puentes, Esteban Rodríguez, Kai Dallmeier, Mariano Esteban, Juan García-Arriaza, Juan García-Arriaza
Published in Frontiers in Immunology (2022-03-01)Get full text
Article -
17
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters by Rana Abdelnabi, Patricia Pérez, Patricia Pérez, David Astorgano, Guillermo Albericio, Winnie Kerstens, Hendrik Jan Thibaut, Lotte Coelmont, Birgit Weynand, Nuria Labiod, Rafael Delgado, Rafael Delgado, Rafael Delgado, Rafael Delgado, Dolores Montenegro, Eugenia Puentes, Esteban Rodríguez, Johan Neyts, Kai Dallmeier, Mariano Esteban, Juan García-Arriaza, Juan García-Arriaza
Published in Frontiers in Immunology (2023-10-01)Get full text
Article
